⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HALO News
Halozyme Therapeutics, Inc.
Rybrevant (Johnson & Johnson) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
JNJ
HALO
Form 8-K
sec.gov
HALO
Halozyme Appoints David Ramsay as Interim Chief Financial Officer
prnewswire.com
HALO
Hylenex (Halozyme Therapeutics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
HALO
U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma
prnewswire.com
HALO
HALOZYME REPORTS FULL YEAR 2025 RECORD REVENUE OF $1.4 BILLION AND REITERATES STRONG 2026 FINANCIAL GUIDANCE
prnewswire.com
HALO
Genmab Publishes 2025 Annual Report
globenewswire.com
GMAB
HALO
ABBV
MRUS
NVS
JNJ
HRZN
Crayola and Ms. Rachel Team Up to Foster Playful Learning Powered by Color
prnewswire.com
HALO
CRAYOLA EXPANDS CREATIVE POSSIBILITIES WITH 2026 INNOVATIONS
prnewswire.com
HALO
CDR-Life Appoints Dimitrios Chondros, MD, as Chief Medical Officer
businesswire.com
HALO